Online Grand Rounds and Video Library

Moving B-yond Cytoxan: New treatments for Lupus Nephritis

Objectives and Disclosures

Participants will be able to:

  • Evaluate pediatric patients for possible systemic lupus erythematosus and lupus nephritis as well as differentiate childhood lupus nephritis from adult-onset manifestations. Identify lupus nephritis patients that need immediate evaluation.
  • Differentiate patients with lupus nephritis that will likely be successful on a treatment regimen with mycophenolate compared to those that should be treated with cyclophosphamide.
  • Compare the effectiveness of different biologic therapies for lupus nephritis with traditional therapies.

Planners and speaker disclose they have no relevant financial relationships.


Daryl Okamura, MD
Associate Professor of Pediatrics, UW
Nephrology, Autoimmune Kidney Disease, Dialysis, Apheresis, Seattle Children’s



Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.

Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Videos are available for only one year after posting.

If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.